Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading ; volume:18 ; number:2 ; day:13 ; month:1 ; year:2023 ; pages:677-680 ; date:3.2023
Internal and emergency medicine ; 18, Heft 2 (13.1.2023), 677-680, 3.2023

Creator: Colangeli, Luca
Aprile, Gianna
Carcone, Clara
D’Adamo, Monica
Medda, Emanuela
Sbraccia, Paolo
Guglielmi, Valeria

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11739-022-03185-5

URN: urn:nbn:de:101:1-2023080509052996113107

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Colangeli, Luca
Aprile, Gianna
Carcone, Clara
D’Adamo, Monica
Medda, Emanuela
Sbraccia, Paolo
Guglielmi, Valeria
SpringerLink (Online service)

Other Objects (12)

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination

Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study

Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

Related objects

Reset password